The National Institutes of Health (NIH) is offering the NIA Advanced Postdoctoral Career Transition Awards to promote diversity in translational research related to Alzheimer's disease and related dementias (AD/ADRD). This funding opportunity aims to support early-career investigators from underrepresented backgrounds, providing them with the necessary training and mentorship to develop critical research skills and transition into independent research roles. The program consists of two phases: the K99 phase for mentored training lasting up to two years, followed by the R00 phase, which offers independent research support for up to three years. Eligible applicants include various institutions and organizations, with a focus on enhancing the diversity of the research workforce. Interested parties should note that the application deadline is July 12, 2027, and can find more information at [NIH Grants](http://grants.nih.gov/grants/guide/pa-files/PAR-24-271.html). For inquiries, contact NIH Grants Information at grantsinfo@nih.gov.

PAR-24-271.html

The National Institutes of Health (NIH) is offering the NIA Advanced Postdoctoral Career Transition Awards to promote diversity in translational research related to Alzheimer's disease and related dementias (AD/ADRD). This funding opportunity aims to support early-career investigators from underrepresented backgrounds, encouraging them to develop critical research skills for transitioning into independent research roles. The K99/R00 award program consists of two phases: the K99 phase for mentored training lasting up to two years, followed by the R00 phase providing independent research support for up to three years. Eligible applicants may include higher education institutions, nonprofits, and government entities. The initiative highlights the need for a diverse research workforce and emphasizes training in areas including drug discovery and behavioral interventions. Key deadlines for applications are set between early 2025 and 2027, with specific guidelines for mentorship and funding distribution. Successful candidates are expected to dedicate significant efforts to career development, integrating mentorship to foster their transition to independence and contribute meaningfully to AD/ADRD research.

https://grants.nih.gov/grants/guide/pa-files/PAR-24-271.html

The purpose of this Notice of Funding Opportunity (NOFO) is to promote diversity in the translational research workforce for Alzheimer&apos;s disease and Alzheimer&apos;s disease-related dementias (AD/ADRD), including frontotemporal dementia, Lewy body dementia, and vascular dementia. This pathway to independence award will support early career investigators from diverse backgrounds to gain critical translational research skills that they can apply to various aspects of AD/ADRD research (from populations studies to research that can lead to new treatments and diagnostics, including all aspects of behavioral and social research). This program will support highly trained translational researchers as they transition to research independence in the field of AD/ADRD . The long-term goal of this program is to exand the pool of translational researchers who can effectively participate in and/or lead a team-science, interdisciplinary approach to studies of AD/ADRD treatment, prevention, early detection, and disease management and care. This Notice of Funding Opportunity (NOFO) is designed for candidates proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary clinical trial. Under this NOFO candidates are permitted to propose a research experience in a clinical trial led by a mentor or co-mentor.

See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.

NIH Grants Information&lt;br/&gt;grantsinfo@nih.gov

Buyer

Eligible Applicants

Funding Category

Funding Instrument

Opportunity Category

Cost Sharing or Matching Requirement

Original Source

Additional Information